152 related articles for article (PubMed ID: 20662852)
1. MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures.
Zuntini M; Salvatore M; Pedrini E; Parra A; Sgariglia F; Magrelli A; Taruscio D; Sangiorgi L
Clin Genet; 2010 Dec; 78(6):507-16. PubMed ID: 20662852
[TBL] [Abstract][Full Text] [Related]
2. The neoplastic pathogenesis of solitary and multiple osteochondromas.
Porter DE; Simpson AH
J Pathol; 1999 Jun; 188(2):119-25. PubMed ID: 10398153
[TBL] [Abstract][Full Text] [Related]
3. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
Stickens D; Brown D; Evans GA
Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
[TBL] [Abstract][Full Text] [Related]
4. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
[TBL] [Abstract][Full Text] [Related]
5. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb).
Jennes I; Pedrini E; Zuntini M; Mordenti M; Balkassmi S; Asteggiano CG; Casey B; Bakker B; Sangiorgi L; Wuyts W
Hum Mutat; 2009 Dec; 30(12):1620-7. PubMed ID: 19810120
[TBL] [Abstract][Full Text] [Related]
6. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
[TBL] [Abstract][Full Text] [Related]
7. Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients.
Szuhai K; Jennes I; de Jong D; Bovée JV; Wiweger M; Wuyts W; Hogendoorn PC
Hum Mutat; 2011 Feb; 32(2):E2036-49. PubMed ID: 21280143
[TBL] [Abstract][Full Text] [Related]
8. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation.
Zuntini M; Pedrini E; Parra A; Sgariglia F; Gentile FV; Pandolfi M; Alberghini M; Sangiorgi L
Oncogene; 2010 Jul; 29(26):3827-34. PubMed ID: 20418910
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
Wuyts W; Van Hul W
Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
[TBL] [Abstract][Full Text] [Related]
10. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.
Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT
J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558
[TBL] [Abstract][Full Text] [Related]
11. Multiple osteochondromas.
Bovée JV
Orphanet J Rare Dis; 2008 Feb; 3():3. PubMed ID: 18271966
[TBL] [Abstract][Full Text] [Related]
12. Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients.
Benoist-Lasselin C; de Margerie E; Gibbs L; Cormier S; Silve C; Nicolas G; LeMerrer M; Mallet JF; Munnich A; Bonaventure J; Zylberberg L; Legeai-Mallet L
Bone; 2006 Jul; 39(1):17-26. PubMed ID: 16476576
[TBL] [Abstract][Full Text] [Related]
13. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
[TBL] [Abstract][Full Text] [Related]
14. The short-lived exostosis induced surgically versus the lasting genetic hereditary multiple exostoses.
Trebicz-Geffen M; Nevo Z; Evron Z; Posternak N; Glaser T; Fridkin M; Kollander Y; Robinson D
Exp Mol Pathol; 2003 Feb; 74(1):40-8. PubMed ID: 12645631
[TBL] [Abstract][Full Text] [Related]
15. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
Wuyts W; Radersma R; Storm K; Vits L
Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
[TBL] [Abstract][Full Text] [Related]
16. EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis.
Bovée JV; Hameetman L; Kroon HM; Aigner T; Hogendoorn PC
J Pathol; 2006 Jul; 209(3):411-9. PubMed ID: 16622899
[TBL] [Abstract][Full Text] [Related]
17. Signaling systems affecting the severity of multiple osteochondromas.
Piombo V; Jochmann K; Hoffmann D; Wuelling M; Vortkamp A
Bone; 2018 Jun; 111():71-81. PubMed ID: 29545125
[TBL] [Abstract][Full Text] [Related]
18. Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas.
Kyriazoglou AI; Dimitriadis E; Arnogiannaki N; Brandal P; Heim S; Pandis N
Cancer Genet; 2011 Dec; 204(12):677-81. PubMed ID: 22285020
[TBL] [Abstract][Full Text] [Related]
19. Dysplasia epiphysealis hemimelica (Trevor disease): a rare developmental disorder of bone mimicking osteochondroma of long bones.
Glick R; Khaldi L; Ptaszynski K; Steiner GC
Hum Pathol; 2007 Aug; 38(8):1265-72. PubMed ID: 17490719
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses.
Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG
J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]